Log In
Print this Print this

Gliovac (ERC1671)

  Manage Alerts
Collapse Summary General Information
Company ERC Belgium S.A.
DescriptionAllogeneic and autologous haptenized and irradiated cells and cell lysates derived from glioma
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationBrain cancer
Indication DetailsTreat glioma
Regulatory Designation U.S. - Orphan Drug (Treat glioma);
EU - Orphan Drug (Treat glioma)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today